OPTR
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
OPTR
Delisted
OPTR was delisted on the 23rd of October, 2013.
104 hedge funds and large institutions have $526M invested in OPTIMER PHARMACEUTICALS, INC. COM STK in 2013 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
74% less call options, than puts
Call options by funds: $1.84M | Put options by funds: $6.99M
Holders
104
Holding in Top 10
–
Calls
$1.84M
Puts
$6.99M
Top Buyers
| 1 | +$36.7M | |
| 2 | +$27.9M | |
| 3 | +$23.2M | |
| 4 |
JG
Jefferies Group
New York
|
+$20.1M |
| 5 |
Morgan Stanley
New York
|
+$18.4M |
Top Sellers
| 1 | -$43.8M | |
| 2 | -$42.5M | |
| 3 | -$38.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$33.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.5M |
